版本:
中国

BRIEF-Concert Pharmaceuticals says announced an unexpected delay in initiation of CTP-543 phase 2a trial

April 5 Concert Pharmaceuticals Inc

* Concert Pharmaceuticals Inc - announced an unexpected delay in initiation of CTP-543 phase 2a trial for alopecia areata

* Concert Pharmaceuticals Inc - concert is investigating issue and is working to remedy situation

* Concert Pharmaceuticals Inc - expects to initiate and enroll trial in 2017 with topline data expected in Q1 of 2018

* Concert Pharmaceuticals - delay in initiation of CTP-543 phase 2a trial for alopecia areata due to a late emerging clinical tablet appearance issue Source text for Eikon: (bit.ly/2oCuCfv) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐